APA (7th ed.) Citation

Kawashiri, S., Kawakami, A., Iwamoto, N., Fujikawa, K., Aramaki, T., Tamai, M., . . . Eguchi, K. (2010). Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics. Modern rheumatology, 20(1), 40-45. https://doi.org/10.3109/s10165-009-0235-4

Chicago Style (17th ed.) Citation

Kawashiri, Shin-ya, et al. "Switching to the Anti-interleukin-6 Receptor Antibody Tocilizumab in Rheumatoid Arthritis Patients Refractory to Antitumor Necrosis Factor Biologics." Modern Rheumatology 20, no. 1 (2010): 40-45. https://doi.org/10.3109/s10165-009-0235-4.

MLA (9th ed.) Citation

Kawashiri, Shin-ya, et al. "Switching to the Anti-interleukin-6 Receptor Antibody Tocilizumab in Rheumatoid Arthritis Patients Refractory to Antitumor Necrosis Factor Biologics." Modern Rheumatology, vol. 20, no. 1, 2010, pp. 40-45, https://doi.org/10.3109/s10165-009-0235-4.